UK Companies House feature
MORNINGSIDE PHARMACEUTICALS LIMITED
Cash
£1M
-76.2% vs 2023
Net assets
£37M
+34.3% vs 2023
Employees
74
-20.4% vs 2023
Profit before tax
£18M
+21% vs 2023
Profile
- Company number
- 02672877
- Status
- Active
- Incorporation
- 1991-12-18
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Net assets
4-year trend · vs UK Healthcare median
Accounts
4-year trend · latest 2024-12-31
| Metric | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | — | — | — | — | |
| Profit before tax | — | — | £14,731,195 | £17,830,750 | |
| Net profit | — | — | £14,257,743 | £16,003,843 | |
| Cash | — | — | £5,700,590 | £1,356,270 | |
| Total assets less current liabilities | — | — | £27,972,743 | £37,466,014 | |
| Net assets | — | — | £27,729,178 | £37,233,021 | |
| Equity | — | — | £27,729,178 | £37,233,021 | |
| Average employees | — | — | 93 | 74 | |
| Wages | — | — | £3,075,907 | £2,953,802 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- TC Group
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HP SECRETARIAL SERVICES LIMITED | Corporate Secretary | 2023-02-09 | — | — |
| BUCKLEY, Gary David | Director | 2023-07-06 | Feb 1986 | British |
| CONDON, Richard Michael | Director | 2022-09-30 | Aug 1976 | British |
| MAY, Jonathan Charles | Director | 2023-07-06 | Apr 1970 | British |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GADHIA, Tarlaben Kishan | Secretary | 1991-12-18 | 2002-12-31 |
| KOTECHA, Monisha Nikesh | Secretary | 2003-01-01 | 2022-09-30 |
| TEMPLE SECRETARIES LIMITED | Corporate Nominee Secretary | 1991-12-18 | 1991-12-18 |
| BRADY, Timothy James | Director | 2021-12-01 | 2025-10-31 |
| FUNG, Clifford Roy | Director | 2021-12-01 | 2025-10-31 |
| GADHIA, Danesh Vinodkumar | Director | 1991-12-18 | 2006-01-19 |
| GADHIA, Tarlaben Kishan | Director | 1991-12-18 | 2002-12-31 |
| HUANG, Yanyan | Director | 2021-12-01 | 2023-05-26 |
| KOTECHA, Monisha Nikesh | Director | 2003-01-01 | 2022-09-30 |
| KOTECHA, Nikesh Rasiklal, Dr | Director | 1996-06-01 | 2022-09-30 |
| COMPANY DIRECTORS LIMITED | Corporate Nominee Director | 1991-12-18 | 1991-12-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Randalsun Capital Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-05-21 | Ceased 2022-09-30 |
| Remedi Medical Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2021-05-21 |
Filing timeline
Last 20 of 132 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-10-31 | TM01 | officers | termination director company with name termination date |
| 2025-10-31 | TM01 | officers | termination director company with name termination date |
| 2025-07-04 | AA | accounts | accounts with accounts type full |
| 2025-03-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-07-25 | AA | accounts | accounts with accounts type full |
| 2024-03-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-07-21 | AA | accounts | accounts with accounts type full |
| 2023-07-10 | AP01 | officers | appoint person director company with name date |
| 2023-07-10 | AP01 | officers | appoint person director company with name date |
| 2023-06-07 | TM01 | officers | termination director company with name termination date |
| 2023-03-09 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-02-13 | AP04 | officers | appoint corporate secretary company with name date |
| 2023-02-06 | PSC08 | persons-with-significant-control | notification of a person with significant control statement |
| 2023-02-06 | PSC09 | persons-with-significant-control | withdrawal of a person with significant control statement |
| 2023-01-17 | RESOLUTIONS | resolution | resolution |
| 2023-01-17 | MA | incorporation | memorandum articles |
| 2023-01-13 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-01-06 | CC02 | change-of-constitution | notice removal restriction on company articles |
| 2023-01-03 | PSC08 | persons-with-significant-control | notification of a person with significant control statement |
Credit score
Altman Z″ (private-firm) · reference 2024-12-31
9.47
SAFE
Altman Z″
- Working capital / Total assets 0.651 × 6.56 = +4.27
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.341 × 6.72 = +2.29
- Book equity / Total liabilities 2.769 × 1.05 = +2.91
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory